nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—ALB—chronic obstructive pulmonary disease	0.349	1	CbGaD
Prasugrel—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.061	0.131	CbGbCtD
Prasugrel—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.061	0.131	CbGbCtD
Prasugrel—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0507	0.109	CbGbCtD
Prasugrel—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0507	0.109	CbGbCtD
Prasugrel—ALB—Prednisone—chronic obstructive pulmonary disease	0.0395	0.085	CbGbCtD
Prasugrel—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0389	0.0837	CbGbCtD
Prasugrel—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0384	0.0826	CbGbCtD
Prasugrel—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0263	0.0565	CbGbCtD
Prasugrel—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0256	0.0551	CbGbCtD
Prasugrel—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0251	0.0539	CbGbCtD
Prasugrel—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0223	0.048	CbGbCtD
Prasugrel—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0131	0.0282	CbGbCtD
Prasugrel—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0124	0.0266	CbGbCtD
Prasugrel—Retroperitoneal haemorrhage—Arformoterol—chronic obstructive pulmonary disease	0.00725	0.0568	CcSEcCtD
Prasugrel—Retroperitoneal haemorrhage—Formoterol—chronic obstructive pulmonary disease	0.00725	0.0568	CcSEcCtD
Prasugrel—Haematochezia—Roflumilast—chronic obstructive pulmonary disease	0.00648	0.0508	CcSEcCtD
Prasugrel—Clopidogrel—CYP1A2—chronic obstructive pulmonary disease	0.00307	1	CrCbGaD
Prasugrel—Atrial fibrillation—Roflumilast—chronic obstructive pulmonary disease	0.002	0.0157	CcSEcCtD
Prasugrel—Hyperlipidaemia—Arformoterol—chronic obstructive pulmonary disease	0.00184	0.0144	CcSEcCtD
Prasugrel—Hyperlipidaemia—Formoterol—chronic obstructive pulmonary disease	0.00184	0.0144	CcSEcCtD
Prasugrel—Hypercholesterolaemia—Tiotropium—chronic obstructive pulmonary disease	0.00173	0.0136	CcSEcCtD
Prasugrel—Contusion—Montelukast—chronic obstructive pulmonary disease	0.00149	0.0117	CcSEcCtD
Prasugrel—Rectal haemorrhage—Formoterol—chronic obstructive pulmonary disease	0.00147	0.0115	CcSEcCtD
Prasugrel—Rectal haemorrhage—Arformoterol—chronic obstructive pulmonary disease	0.00147	0.0115	CcSEcCtD
Prasugrel—Atrial fibrillation—Aminophylline—chronic obstructive pulmonary disease	0.00133	0.0104	CcSEcCtD
Prasugrel—Neoplasm—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00938	CcSEcCtD
Prasugrel—Neoplasm—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00938	CcSEcCtD
Prasugrel—Pain in extremity—Tiotropium—chronic obstructive pulmonary disease	0.00119	0.00934	CcSEcCtD
Prasugrel—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.00928	CcSEcCtD
Prasugrel—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.00926	CcSEcCtD
Prasugrel—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.0011	0.00865	CcSEcCtD
Prasugrel—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00104	0.00817	CcSEcCtD
Prasugrel—Atrial fibrillation—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00795	CcSEcCtD
Prasugrel—Atrial fibrillation—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00795	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.000964	0.00756	CcSEcCtD
Prasugrel—Atrial fibrillation—Salbutamol—chronic obstructive pulmonary disease	0.000958	0.00751	CcSEcCtD
Prasugrel—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.000928	0.00727	CcSEcCtD
Prasugrel—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000904	0.00709	CcSEcCtD
Prasugrel—Epistaxis—Tiotropium—chronic obstructive pulmonary disease	0.000866	0.00679	CcSEcCtD
Prasugrel—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.000814	0.00638	CcSEcCtD
Prasugrel—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.000812	0.00636	CcSEcCtD
Prasugrel—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.000808	0.00633	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000804	0.0063	CcSEcCtD
Prasugrel—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000802	0.00629	CcSEcCtD
Prasugrel—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.00077	0.00604	CcSEcCtD
Prasugrel—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.000747	0.00586	CcSEcCtD
Prasugrel—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000744	0.00583	CcSEcCtD
Prasugrel—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000742	0.00582	CcSEcCtD
Prasugrel—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.000706	0.00554	CcSEcCtD
Prasugrel—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.000706	0.00554	CcSEcCtD
Prasugrel—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.000694	0.00544	CcSEcCtD
Prasugrel—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000686	0.00538	CcSEcCtD
Prasugrel—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.000684	0.00536	CcSEcCtD
Prasugrel—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000668	0.00523	CcSEcCtD
Prasugrel—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.000667	0.00523	CcSEcCtD
Prasugrel—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.00066	0.00517	CcSEcCtD
Prasugrel—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.000657	0.00515	CcSEcCtD
Prasugrel—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.000657	0.00515	CcSEcCtD
Prasugrel—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000655	0.00514	CcSEcCtD
Prasugrel—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.000655	0.00513	CcSEcCtD
Prasugrel—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.000655	0.00513	CcSEcCtD
Prasugrel—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000652	0.00511	CcSEcCtD
Prasugrel—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.000652	0.00511	CcSEcCtD
Prasugrel—Ecchymosis—Prednisolone—chronic obstructive pulmonary disease	0.000648	0.00508	CcSEcCtD
Prasugrel—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.000643	0.00504	CcSEcCtD
Prasugrel—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.000638	0.005	CcSEcCtD
Prasugrel—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000637	0.00499	CcSEcCtD
Prasugrel—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.000631	0.00495	CcSEcCtD
Prasugrel—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.000628	0.00492	CcSEcCtD
Prasugrel—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000626	0.00491	CcSEcCtD
Prasugrel—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000621	0.00487	CcSEcCtD
Prasugrel—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.00062	0.00486	CcSEcCtD
Prasugrel—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000619	0.00485	CcSEcCtD
Prasugrel—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000615	0.00482	CcSEcCtD
Prasugrel—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000615	0.00482	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000606	0.00475	CcSEcCtD
Prasugrel—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000601	0.00471	CcSEcCtD
Prasugrel—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000601	0.00471	CcSEcCtD
Prasugrel—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000599	0.0047	CcSEcCtD
Prasugrel—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000599	0.0047	CcSEcCtD
Prasugrel—Contusion—Prednisone—chronic obstructive pulmonary disease	0.000597	0.00468	CcSEcCtD
Prasugrel—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000588	0.00461	CcSEcCtD
Prasugrel—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000587	0.0046	CcSEcCtD
Prasugrel—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000587	0.0046	CcSEcCtD
Prasugrel—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000586	0.0046	CcSEcCtD
Prasugrel—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000583	0.00457	CcSEcCtD
Prasugrel—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00058	0.00455	CcSEcCtD
Prasugrel—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00057	0.00447	CcSEcCtD
Prasugrel—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000569	0.00446	CcSEcCtD
Prasugrel—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000567	0.00445	CcSEcCtD
Prasugrel—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000566	0.00444	CcSEcCtD
Prasugrel—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00056	0.00439	CcSEcCtD
Prasugrel—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00056	0.00439	CcSEcCtD
Prasugrel—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000553	0.00433	CcSEcCtD
Prasugrel—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.000551	0.00432	CcSEcCtD
Prasugrel—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000529	0.00415	CcSEcCtD
Prasugrel—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000529	0.00415	CcSEcCtD
Prasugrel—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000529	0.00414	CcSEcCtD
Prasugrel—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000518	0.00406	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000505	0.00396	CcSEcCtD
Prasugrel—Cough—Formoterol—chronic obstructive pulmonary disease	0.000505	0.00396	CcSEcCtD
Prasugrel—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000505	0.00396	CcSEcCtD
Prasugrel—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.0005	0.00392	CcSEcCtD
Prasugrel—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.0005	0.00392	CcSEcCtD
Prasugrel—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000499	0.00391	CcSEcCtD
Prasugrel—Cough—Montelukast—chronic obstructive pulmonary disease	0.000495	0.00388	CcSEcCtD
Prasugrel—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000491	0.00385	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000489	0.00384	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000489	0.00384	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000479	0.00376	CcSEcCtD
Prasugrel—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000477	0.00374	CcSEcCtD
Prasugrel—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000472	0.0037	CcSEcCtD
Prasugrel—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000472	0.0037	CcSEcCtD
Prasugrel—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000472	0.0037	CcSEcCtD
Prasugrel—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000471	0.00369	CcSEcCtD
Prasugrel—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000463	0.00363	CcSEcCtD
Prasugrel—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000459	0.0036	CcSEcCtD
Prasugrel—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000459	0.0036	CcSEcCtD
Prasugrel—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000457	0.00358	CcSEcCtD
Prasugrel—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000453	0.00355	CcSEcCtD
Prasugrel—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000449	0.00352	CcSEcCtD
Prasugrel—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000446	0.0035	CcSEcCtD
Prasugrel—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000441	0.00346	CcSEcCtD
Prasugrel—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000441	0.00346	CcSEcCtD
Prasugrel—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000433	0.0034	CcSEcCtD
Prasugrel—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000431	0.00338	CcSEcCtD
Prasugrel—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000425	0.00333	CcSEcCtD
Prasugrel—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000421	0.0033	CcSEcCtD
Prasugrel—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000421	0.0033	CcSEcCtD
Prasugrel—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000417	0.00327	CcSEcCtD
Prasugrel—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00041	0.00322	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000408	0.0032	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000408	0.0032	CcSEcCtD
Prasugrel—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000407	0.00319	CcSEcCtD
Prasugrel—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000407	0.00319	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000399	0.00313	CcSEcCtD
Prasugrel—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000399	0.00313	CcSEcCtD
Prasugrel—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000398	0.00312	CcSEcCtD
Prasugrel—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000391	0.00307	CcSEcCtD
Prasugrel—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000391	0.00306	CcSEcCtD
Prasugrel—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000389	0.00305	CcSEcCtD
Prasugrel—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000387	0.00303	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000385	0.00302	CcSEcCtD
Prasugrel—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000385	0.00301	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000378	0.00297	CcSEcCtD
Prasugrel—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000373	0.00293	CcSEcCtD
Prasugrel—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000373	0.00293	CcSEcCtD
Prasugrel—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000369	0.00289	CcSEcCtD
Prasugrel—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000369	0.00289	CcSEcCtD
Prasugrel—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000369	0.00289	CcSEcCtD
Prasugrel—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000367	0.00287	CcSEcCtD
Prasugrel—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000367	0.00287	CcSEcCtD
Prasugrel—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000366	0.00287	CcSEcCtD
Prasugrel—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000362	0.00284	CcSEcCtD
Prasugrel—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00036	0.00282	CcSEcCtD
Prasugrel—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000353	0.00276	CcSEcCtD
Prasugrel—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000348	0.00273	CcSEcCtD
Prasugrel—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000348	0.00273	CcSEcCtD
Prasugrel—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000348	0.00273	CcSEcCtD
Prasugrel—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000341	0.00267	CcSEcCtD
Prasugrel—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000339	0.00266	CcSEcCtD
Prasugrel—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.00266	CcSEcCtD
Prasugrel—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000332	0.0026	CcSEcCtD
Prasugrel—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000329	0.00258	CcSEcCtD
Prasugrel—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000323	0.00253	CcSEcCtD
Prasugrel—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000323	0.00253	CcSEcCtD
Prasugrel—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00251	CcSEcCtD
Prasugrel—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000317	0.00248	CcSEcCtD
Prasugrel—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000312	0.00245	CcSEcCtD
Prasugrel—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000312	0.00245	CcSEcCtD
Prasugrel—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000306	0.0024	CcSEcCtD
Prasugrel—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.00239	CcSEcCtD
Prasugrel—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00233	CcSEcCtD
Prasugrel—Rash—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00233	CcSEcCtD
Prasugrel—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00233	CcSEcCtD
Prasugrel—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00233	CcSEcCtD
Prasugrel—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.00232	CcSEcCtD
Prasugrel—Headache—Formoterol—chronic obstructive pulmonary disease	0.000296	0.00232	CcSEcCtD
Prasugrel—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.00231	CcSEcCtD
Prasugrel—Rash—Montelukast—chronic obstructive pulmonary disease	0.000292	0.00229	CcSEcCtD
Prasugrel—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000291	0.00228	CcSEcCtD
Prasugrel—Headache—Montelukast—chronic obstructive pulmonary disease	0.00029	0.00227	CcSEcCtD
Prasugrel—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000286	0.00225	CcSEcCtD
Prasugrel—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.0022	CcSEcCtD
Prasugrel—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.0022	CcSEcCtD
Prasugrel—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000281	0.0022	CcSEcCtD
Prasugrel—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000281	0.0022	CcSEcCtD
Prasugrel—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00219	CcSEcCtD
Prasugrel—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000275	0.00215	CcSEcCtD
Prasugrel—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000271	0.00212	CcSEcCtD
Prasugrel—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000266	0.00209	CcSEcCtD
Prasugrel—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00208	CcSEcCtD
Prasugrel—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000263	0.00206	CcSEcCtD
Prasugrel—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000262	0.00205	CcSEcCtD
Prasugrel—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000256	0.00201	CcSEcCtD
Prasugrel—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000245	0.00192	CcSEcCtD
Prasugrel—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000237	0.00186	CcSEcCtD
Prasugrel—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000236	0.00185	CcSEcCtD
Prasugrel—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000211	0.00165	CcSEcCtD
Prasugrel—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000208	0.00163	CcSEcCtD
Prasugrel—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000197	0.00154	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000193	0.00151	CcSEcCtD
Prasugrel—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000188	0.00148	CcSEcCtD
Prasugrel—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000186	0.00146	CcSEcCtD
Prasugrel—P2RY12—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000184	0.00332	CbGpPWpGaD
Prasugrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000184	0.00332	CbGpPWpGaD
Prasugrel—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000181	0.00327	CbGpPWpGaD
Prasugrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000181	0.00326	CbGpPWpGaD
Prasugrel—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000181	0.00142	CcSEcCtD
Prasugrel—P2RY12—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000179	0.00322	CbGpPWpGaD
Prasugrel—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000177	0.0032	CbGpPWpGaD
Prasugrel—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000175	0.00316	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000173	0.00312	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000172	0.0031	CbGpPWpGaD
Prasugrel—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000169	0.00133	CcSEcCtD
Prasugrel—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000164	0.00295	CbGpPWpGaD
Prasugrel—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.00126	CcSEcCtD
Prasugrel—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.00126	CcSEcCtD
Prasugrel—P2RY12—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.00016	0.00289	CbGpPWpGaD
Prasugrel—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.00016	0.00126	CcSEcCtD
Prasugrel—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.00126	CcSEcCtD
Prasugrel—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000159	0.00287	CbGpPWpGaD
Prasugrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000158	0.00285	CbGpPWpGaD
Prasugrel—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000158	0.00284	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000156	0.00282	CbGpPWpGaD
Prasugrel—P2RY12—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000154	0.00277	CbGpPWpGaD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000152	0.00275	CbGpPWpGaD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000152	0.00274	CbGpPWpGaD
Prasugrel—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.00119	CcSEcCtD
Prasugrel—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000152	0.00273	CbGpPWpGaD
Prasugrel—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000149	0.00269	CbGpPWpGaD
Prasugrel—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000147	0.00115	CcSEcCtD
Prasugrel—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000145	0.00261	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000145	0.00261	CbGpPWpGaD
Prasugrel—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000144	0.00259	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000143	0.00258	CbGpPWpGaD
Prasugrel—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000141	0.00255	CbGpPWpGaD
Prasugrel—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00014	0.00252	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000139	0.0025	CbGpPWpGaD
Prasugrel—P2RY12—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000138	0.00248	CbGpPWpGaD
Prasugrel—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00107	CcSEcCtD
Prasugrel—CYP2B6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000133	0.00241	CbGpPWpGaD
Prasugrel—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00105	CcSEcCtD
Prasugrel—CYP2B6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000132	0.00238	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.000129	0.00233	CbGpPWpGaD
Prasugrel—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000129	0.00232	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000127	0.0023	CbGpPWpGaD
Prasugrel—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.00229	CbGpPWpGaD
Prasugrel—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000997	CcSEcCtD
Prasugrel—P2RY12—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000126	0.00227	CbGpPWpGaD
Prasugrel—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000964	CcSEcCtD
Prasugrel—P2RY12—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000123	0.00221	CbGpPWpGaD
Prasugrel—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000122	0.0022	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000122	0.0022	CbGpPWpGaD
Prasugrel—P2RY12—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.00012	0.00217	CbGpPWpGaD
Prasugrel—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00012	0.00216	CbGpPWpGaD
Prasugrel—Rash—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000919	CcSEcCtD
Prasugrel—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000918	CcSEcCtD
Prasugrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000117	0.00211	CbGpPWpGaD
Prasugrel—Headache—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000913	CcSEcCtD
Prasugrel—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000115	0.00208	CbGpPWpGaD
Prasugrel—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000115	0.00207	CbGpPWpGaD
Prasugrel—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.002	CbGpPWpGaD
Prasugrel—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000866	CcSEcCtD
Prasugrel—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000109	0.00197	CbGpPWpGaD
Prasugrel—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.0019	CbGpPWpGaD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000105	0.00189	CbGpPWpGaD
Prasugrel—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.00188	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000103	0.00186	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000103	0.00185	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000102	0.00184	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000101	0.00183	CbGpPWpGaD
Prasugrel—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000101	0.00182	CbGpPWpGaD
Prasugrel—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.97e-05	0.0018	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	9.94e-05	0.00179	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	9.93e-05	0.00179	CbGpPWpGaD
Prasugrel—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	9.92e-05	0.00179	CbGpPWpGaD
Prasugrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	9.76e-05	0.00176	CbGpPWpGaD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	9.61e-05	0.00173	CbGpPWpGaD
Prasugrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.49e-05	0.00171	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—NOS2—chronic obstructive pulmonary disease	9.32e-05	0.00168	CbGpPWpGaD
Prasugrel—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.25e-05	0.00167	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	9.23e-05	0.00166	CbGpPWpGaD
Prasugrel—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.19e-05	0.00166	CbGpPWpGaD
Prasugrel—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.12e-05	0.00164	CbGpPWpGaD
Prasugrel—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.09e-05	0.00164	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	8.91e-05	0.00161	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	8.7e-05	0.00157	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	8.61e-05	0.00155	CbGpPWpGaD
Prasugrel—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	8.52e-05	0.00154	CbGpPWpGaD
Prasugrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.5e-05	0.00153	CbGpPWpGaD
Prasugrel—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.5e-05	0.00153	CbGpPWpGaD
Prasugrel—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.39e-05	0.00151	CbGpPWpGaD
Prasugrel—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.38e-05	0.00151	CbGpPWpGaD
Prasugrel—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.38e-05	0.00151	CbGpPWpGaD
Prasugrel—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.26e-05	0.00149	CbGpPWpGaD
Prasugrel—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	8.12e-05	0.00146	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	8.07e-05	0.00146	CbGpPWpGaD
Prasugrel—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.06e-05	0.00145	CbGpPWpGaD
Prasugrel—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.95e-05	0.00143	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	7.9e-05	0.00142	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	7.89e-05	0.00142	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.89e-05	0.00142	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	7.85e-05	0.00142	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—ALB—chronic obstructive pulmonary disease	7.83e-05	0.00141	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	7.77e-05	0.0014	CbGpPWpGaD
Prasugrel—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.64e-05	0.00138	CbGpPWpGaD
Prasugrel—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.53e-05	0.00136	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—NOS3—chronic obstructive pulmonary disease	7.49e-05	0.00135	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.44e-05	0.00134	CbGpPWpGaD
Prasugrel—P2RY12—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	7.43e-05	0.00134	CbGpPWpGaD
Prasugrel—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	7.2e-05	0.0013	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.09e-05	0.00128	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	7.06e-05	0.00127	CbGpPWpGaD
Prasugrel—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.99e-05	0.00126	CbGpPWpGaD
Prasugrel—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.89e-05	0.00124	CbGpPWpGaD
Prasugrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.89e-05	0.00124	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	6.8e-05	0.00123	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	6.48e-05	0.00117	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.46e-05	0.00117	CbGpPWpGaD
Prasugrel—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.42e-05	0.00116	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	6.41e-05	0.00116	CbGpPWpGaD
Prasugrel—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.37e-05	0.00115	CbGpPWpGaD
Prasugrel—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.33e-05	0.00114	CbGpPWpGaD
Prasugrel—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.28e-05	0.00113	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.17e-05	0.00111	CbGpPWpGaD
Prasugrel—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.09e-05	0.0011	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.06e-05	0.00109	CbGpPWpGaD
Prasugrel—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6e-05	0.00108	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.99e-05	0.00108	CbGpPWpGaD
Prasugrel—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	5.86e-05	0.00106	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	5.86e-05	0.00106	CbGpPWpGaD
Prasugrel—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.86e-05	0.00106	CbGpPWpGaD
Prasugrel—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	5.81e-05	0.00105	CbGpPWpGaD
Prasugrel—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.77e-05	0.00104	CbGpPWpGaD
Prasugrel—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	5.58e-05	0.00101	CbGpPWpGaD
Prasugrel—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.55e-05	0.001	CbGpPWpGaD
Prasugrel—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.47e-05	0.000987	CbGpPWpGaD
Prasugrel—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	5.46e-05	0.000984	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.44e-05	0.000981	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—VEGFA—chronic obstructive pulmonary disease	5.4e-05	0.000973	CbGpPWpGaD
Prasugrel—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	5.38e-05	0.00097	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	5.16e-05	0.000931	CbGpPWpGaD
Prasugrel—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	5.12e-05	0.000924	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	5.12e-05	0.000923	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.06e-05	0.000912	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.04e-05	0.000908	CbGpPWpGaD
Prasugrel—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.97e-05	0.000896	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—TGFB1—chronic obstructive pulmonary disease	4.95e-05	0.000893	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	4.9e-05	0.000883	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	4.73e-05	0.000852	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.67e-05	0.000841	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	4.65e-05	0.000839	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	4.47e-05	0.000805	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	4.44e-05	0.0008	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.29e-05	0.000774	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.2e-05	0.000758	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.2e-05	0.000757	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	4.18e-05	0.000753	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.17e-05	0.000752	CbGpPWpGaD
Prasugrel—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.14e-05	0.000747	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—TP53—chronic obstructive pulmonary disease	4.08e-05	0.000735	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	3.98e-05	0.000718	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.89e-05	0.000701	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.88e-05	0.0007	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.86e-05	0.000696	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.81e-05	0.000688	CbGpPWpGaD
Prasugrel—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.81e-05	0.000687	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.79e-05	0.000683	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	3.78e-05	0.000681	CbGpPWpGaD
Prasugrel—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.76e-05	0.000677	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.66e-05	0.00066	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.65e-05	0.000658	CbGpPWpGaD
Prasugrel—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.61e-05	0.000652	CbGpPWpGaD
Prasugrel—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.61e-05	0.000651	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	3.59e-05	0.000647	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.58e-05	0.000646	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GC—chronic obstructive pulmonary disease	3.52e-05	0.000634	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.49e-05	0.00063	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.39e-05	0.000611	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.27e-05	0.000589	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.24e-05	0.000585	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.22e-05	0.00058	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.18e-05	0.000574	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	3.16e-05	0.000569	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.96e-05	0.000533	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.95e-05	0.000531	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.93e-05	0.000529	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.93e-05	0.000529	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.88e-05	0.000519	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.8e-05	0.000505	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.79e-05	0.000503	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.68e-05	0.000482	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.66e-05	0.00048	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.6e-05	0.00047	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.6e-05	0.000469	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.57e-05	0.000463	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.54e-05	0.000458	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.52e-05	0.000454	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.39e-05	0.00043	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.34e-05	0.000422	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.31e-05	0.000417	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.28e-05	0.000411	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.26e-05	0.000407	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.25e-05	0.000406	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.14e-05	0.000386	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.13e-05	0.000384	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.06e-05	0.000371	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.04e-05	0.000367	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.95e-05	0.000352	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.95e-05	0.000351	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.92e-05	0.000346	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.9e-05	0.000342	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.9e-05	0.000342	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.9e-05	0.000342	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.86e-05	0.000335	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.83e-05	0.00033	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.76e-05	0.000318	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.73e-05	0.000312	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.72e-05	0.000311	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.7e-05	0.000307	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.68e-05	0.000303	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.65e-05	0.000297	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.6e-05	0.000288	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.59e-05	0.000287	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.58e-05	0.000285	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.57e-05	0.000283	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.56e-05	0.000281	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.56e-05	0.00028	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.55e-05	0.00028	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.45e-05	0.000262	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.45e-05	0.000261	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.43e-05	0.000258	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.42e-05	0.000256	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.38e-05	0.000249	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.38e-05	0.000248	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.34e-05	0.000242	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.33e-05	0.00024	CbGpPWpGaD
Prasugrel—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.31e-05	0.000237	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.31e-05	0.000236	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.27e-05	0.000228	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.23e-05	0.000222	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.22e-05	0.000221	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.2e-05	0.000215	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.18e-05	0.000213	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.16e-05	0.000209	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.1e-05	0.000198	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.09e-05	0.000196	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.07e-05	0.000194	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.04e-05	0.000188	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.04e-05	0.000187	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.02e-05	0.000185	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	1.01e-05	0.000183	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1e-05	0.000181	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.49e-06	0.000171	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	9.36e-06	0.000169	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	9.35e-06	0.000169	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	8.96e-06	0.000162	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.62e-06	0.000155	CbGpPWpGaD
Prasugrel—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	7.54e-06	0.000136	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.19e-06	0.00013	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.09e-06	0.000128	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	7.08e-06	0.000128	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	6.77e-06	0.000122	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.6e-06	0.000119	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	6.45e-06	0.000116	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.26e-06	0.000113	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	6.17e-06	0.000111	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.26e-06	7.67e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.07e-06	7.34e-05	CbGpPWpGaD
